{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:46:40Z","timestamp":1783644400320,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.ejphar.2006.09.007","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T14:30:32Z","timestamp":1158676232000},"page":"27-33","source":"Crossref","is-referenced-by-count":55,"title":["Imatinib mesylate (Gleevec\u00ae) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity"],"prefix":"10.1016","volume":"551","author":[{"given":"Iman","family":"El Hajj Dib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marl\u00e8ne","family":"Gallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Mentaverri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"S\u00e9venet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Brazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.09.007_bib1","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1093\/emboj\/cdg635","article-title":"Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim","volume":"22","author":"Akiyama","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2006.09.007_bib2","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa051140","article-title":"Altered bone and mineral metabolism in patients receiving imatinib mesylate","volume":"354","author":"Berman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2006.09.007_bib3","first-page":"139","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors","volume":"295","author":"Buchdunger","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.09.007_bib4","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1182\/blood.V90.12.4947","article-title":"CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins","volume":"90","author":"Carroll","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2006.09.007_bib5","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1172\/JCI8672","article-title":"M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss","volume":"105","author":"Cenci","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2006.09.007_bib6","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1073\/pnas.0502000102","article-title":"Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580","volume":"102","author":"Conway","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2006.09.007_bib7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.cdd.4400400","article-title":"Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR-ABL tyrosine kinase, CGP 57148","volume":"5","author":"Dan","year":"1998","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2006.09.007_bib8","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood-2004-10-3967","article-title":"Macrophage colony-stimulating factor receptor c-FMS is a novel target of imatinib","volume":"105","author":"Dewar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2006.09.007_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1440-1711.2004.01296.x","article-title":"Imatinib inhibits the functional capacity of cultured human monocytes","volume":"83","author":"Dewar","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ejphar.2006.09.007_bib10","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1182\/blood-2005-09-3568","article-title":"Imatinib as a potential anti-resorptive therapy for bone disease","author":"Dewar","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2006.09.007_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.5650050716","article-title":"Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op\/op mouse","volume":"5","author":"Felix","year":"1990","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2006.09.007_bib12","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E","article-title":"The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis","volume":"44","author":"Frith","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2006.09.007_bib13","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1084\/jem.178.5.1733","article-title":"Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts","volume":"178","author":"Fuller","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2006.09.007_bib14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbrc.2004.05.033","article-title":"Breast cancer cell line MDA-MB 231 exerts a potent and direct anti-apoptotic effect on mature osteoclasts","volume":"319","author":"Gallet","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2006.09.007_bib15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.cdd.4401285","article-title":"M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR\/S6 kinase","volume":"10","author":"Glantschnig","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2006.09.007_bib16","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.89.20.9637","article-title":"Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-FMS, in murine osteoclasts","volume":"89","author":"Hofstetter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2006.09.007_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/mp.50.3.132","article-title":"Apoptosis in bone physiology and disease","volume":"50","author":"Hughes","year":"1997","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.ejphar.2006.09.007_bib18","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2006.09.007_bib19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1210\/en.136.2.808","article-title":"Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells","volume":"136","author":"Jimi","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2006.09.007_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1006\/bbrc.1995.1251","article-title":"Detection and characterization of apoptosis in osteoclasts in vitro","volume":"207","author":"Kameda","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2006.09.007_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.186.4.489","article-title":"Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts","volume":"186","author":"Kameda","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2006.09.007_bib22","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2741\/1102","article-title":"Osteoclasts, pro-inflammatory cytokines, RANK-L and bone remodeling in rheumatoid arthritis","volume":"8","author":"Kaplan","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejphar.2006.09.007_bib23","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1172\/JCI26132","article-title":"M-CSF mediates TNF-induced inflammatory osteolysis","volume":"115","author":"Kitaura","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2006.09.007_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/jsre.2001.6204","article-title":"Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells","volume":"100","author":"Mancino","year":"2001","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2006.09.007_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/er.21.2.115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2006.09.007_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:CLIN.0000006873.65590.68","article-title":"SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model","volume":"20","author":"Murray","year":"2003","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.ejphar.2006.09.007_bib27","first-page":"1958","article-title":"The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X","volume":"6","author":"Oetzel","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2006.09.007_bib28","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1182\/blood-2003-05-1605","article-title":"A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity","volume":"103","author":"Okada","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2006.09.007_bib29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jbmr.5650110203","article-title":"A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates","volume":"11","author":"Parfitt","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2006.09.007_bib30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.2004.03.050","article-title":"Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients","volume":"22","author":"Peng","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2006.09.007_bib31","doi-asserted-by":"crossref","first-page":"34967","DOI":"10.1074\/jbc.274.49.34967","article-title":"Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase","volume":"274","author":"Reszka","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2006.09.007_bib32","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2006.09.007_bib33","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2001.19.15.3562","article-title":"Biology of osteoclast activation in cancer","volume":"19","author":"Roodman","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2006.09.007_bib34","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1074\/jbc.M410480200","article-title":"Akt1\/Akt2 and mammalian target of rapamycin\/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors","volume":"280","author":"Sugatani","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2006.09.007_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1172\/JCI116179","article-title":"Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors","volume":"91","author":"Tanaka","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2006.09.007_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.0105-2896.2005.00327.x","article-title":"Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL\u2013RANK signaling system","volume":"208","author":"Tanaka","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2006.09.007_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.onc.1209007","article-title":"FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance","volume":"25","author":"Taylor","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2006.09.007_bib38","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2006.09.007_bib39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0006-291X(92)90832-6","article-title":"Identification of osteopontin in isolated rabbit osteoclasts","volume":"186","author":"Tezuka","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2006.09.007_bib40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.addr.2004.12.018","article-title":"Mechanism of osteoclast mediated bone resorption-rationale for the design of new therapeutics","volume":"57","author":"Vaananen","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2006.09.007_bib41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.bbrc.2004.11.072","article-title":"Regulation of apoptosis in osteoclasts and osteoblastic cells","volume":"328","author":"Xing","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2006.09.007_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/8756-3282(96)00013-0","article-title":"Functions of the M-CSF receptor on osteoclasts","volume":"18","author":"Yang","year":"1996","journal-title":"Bone"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906010077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906010077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T08:10:35Z","timestamp":1587197435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299906010077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":42,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0014299906010077"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.09.007","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}